{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:45:22Z","timestamp":1793371522505,"version":"4.5.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017957","name":"Health Commission of Guizhou Province","doi-asserted-by":"publisher","award":["2024GZWJKJXM0873"],"award-info":[{"award-number":["2024GZWJKJXM0873"]}],"id":[{"id":"10.13039\/100017957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Primary aldosteronism (PA) and autoimmune polyglandular syndrome type 2 (APS-2) represent opposing ends of adrenal pathology\u2014hyperfunction versus hypofunction. Their coexistence is exceptionally rare and diagnostically challenging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 73-year-old woman with a 30-year history of refractory hypertension and recent hyponatremia was diagnosed with PA (aldosterone-to-renin ratio 29.11, positive captopril challenge, left adrenal hyperplasia). Spironolactone controlled blood pressure but paradoxically worsened hyponatremia. Two independent circadian cortisol profiles confirmed persistently low cortisol with preserved normal rhythm (first: 118.65\/100.80\/50.25 nmol\/L; second: 133.34\/71.62\/39.12 nmol\/L at 08:00\/16:00\/00:00). In contrast, plasma ACTH levels sent to an external laboratory showed no circadian variation (08:00 7.19 pmol\/L, 16:00 1.21 pmol\/L, 00:00 1.68 pmol\/L; reference 1.60-13.90 pmol\/L). This discordance-preserved cortisol rhythmicity with absent ACTH rhythm-raised the possibility of a preanalytical artifact rather than secondary adrenal insufficiency, although this inference could not be definitively proven. Physical examination revealed skin hyperpigmentation, and her history of Hashimoto\u2019s thyroiditis supported a clinically probable diagnosis of APS-2 (clinically probable Addison\u2019s disease with autoimmune thyroid disease), given the absence of confirmatory 21-hydroxylase antibody testing and ACTH-stimulation testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention and outcomes<\/jats:title>\n                    <jats:p>Prednisone 5 mg daily was added to her regimen of spironolactone and levothyroxine. Her symptoms resolved, and serum sodium normalized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This report describes a rare case of primary aldosteronism occurring in the setting of clinically probable APS-2. The discordant cortisol-ACTH pattern serves as a critical reminder that ACTH is highly labile; clinicians must interpret results holistically, integrating clinical context and circadian patterns, and remain mindful of diagnostic uncertainty when confirmatory assays cannot be completed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1954159","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:43:55Z","timestamp":1790228635000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Primary aldosteronism coexisting with adrenal insufficiency in a 73-year-old woman with paradoxical hyponatremia"],"prefix":"10.3389","volume":"17","author":[{"given":"Minghong","family":"Luo","sequence":"first","affiliation":[{"name":"Kweichow Moutai Hospital, Moutai Group","place":["Renhuai, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifang","family":"Qin","sequence":"additional","affiliation":[{"name":"Kweichow Moutai Hospital, Moutai Group","place":["Renhuai, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Guizhou Provincial People\u2019s Hospital","place":["Guiyang, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxian","family":"Tu","sequence":"additional","affiliation":[{"name":"The First People\u2019s Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University)","place":["Zunyi, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhao","sequence":"additional","affiliation":[{"name":"The First People\u2019s Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University)","place":["Zunyi, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghui","family":"Li","sequence":"additional","affiliation":[{"name":"The First People\u2019s Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University)","place":["Zunyi, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiya","family":"Zeng","sequence":"additional","affiliation":[{"name":"The First People\u2019s Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University)","place":["Zunyi, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Wang","sequence":"additional","affiliation":[{"name":"The First People\u2019s Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University)","place":["Zunyi, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[{"name":"The First People\u2019s Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University)","place":["Zunyi, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianfeng","family":"Jiang","sequence":"additional","affiliation":[{"name":"The First People\u2019s Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University)","place":["Zunyi, Guizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: Case detection, diagnosis, and treatment: An endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.02561.x","article-title":"Autoimmune polyglandular syndrome type 2: The tip of an iceberg","volume":"137","author":"Betterle","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.9256","article-title":"Primary hyperaldosteronism associated with type 3 autoimmune polyendocrine syndrome: A rare case report","volume":"12","author":"Li","year":"2024","journal-title":"Clin Case Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9629(15)33944-6","article-title":"A patient with concurrent primary hyperaldosteronism and adrenal insufficiency","volume":"328","author":"Puentes","year":"2004","journal-title":"Am J Med Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","article-title":"International histopathology consensus for unilateral primary aldosteronism","volume":"106","author":"Williams","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2019.100819","article-title":"The hypothalamic-pituitary-adrenal axis as a substrate for stress resilience: Interactions with the circadian clock","volume":"56","author":"Kinlein","year":"2020","journal-title":"Front Neuroendocrinol"},{"key":"B7","volume-title":"Polyglandular Autoimmune Syndrome Type II","author":"Singh","year":"2026"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1563629","article-title":"Delayed diagnosis of the full triad autoimmune polyendocrine syndrome type 2 with adrenal crisis: A case report and literature review","volume":"16","author":"Yao","year":"2025","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.11613\/bm.2025.010502","article-title":"Is the stability of ACTH in whole blood a genuine concern during the preanalytical phase? A systematic review","volume":"35","author":"Dib","year":"2025","journal-title":"Biochem Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.11613\/bm.2024.030702","article-title":"Stability of adrenocorticotropic hormone in whole blood samples: Effects of storage conditions","volume":"34","author":"Fraissinet","year":"2024","journal-title":"Biochem Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: An endocrine society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.clinbiochem.2020.04.004","article-title":"Evaluation of plasma ACTH stability using the Roche Elecsys immunoassay","volume":"81","author":"Nandakumar","year":"2020","journal-title":"Clin Biochem"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.86299","article-title":"Thyroxine reveals Addison's disease: A case report","volume":"17","author":"Tsinopoulou","year":"2025","journal-title":"Cureus"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2174\/1574886315666200826095842","article-title":"Adrenocortical crisis triggered by levothyroxine in an unrecognized autoimmune polyglandular syndrome type-2: A case report with review of the literature","volume":"16","author":"Patel","year":"2021","journal-title":"Curr Drug Saf"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj1954.39.563","article-title":"Clinical significance of adrenal computed tomography in Addison's disease","volume":"39","author":"Sun","year":"1992","journal-title":"Endocrinologia Japonica"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.12890\/2024_004627","article-title":"A silent cause of shock: Autoimmune polyglandular syndromes","volume":"11","author":"Colantonio","year":"2024","journal-title":"Eur J Case Rep Internal Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.5485","article-title":"Adrenal insufficiency in adults: A review","volume":"334","author":"Vaidya","year":"2025","journal-title":"Jama"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaf136","article-title":"Dehydroepiandrosterone sulfate in diagnosing mild autonomous cortisol secretion and adrenal insufficiency","volume":"9","author":"Saini","year":"2025","journal-title":"J Endocr Soc"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae855","article-title":"Performance of dehydroepiandrosterone sulfate and baseline cortisol in assessing adrenal insufficiency","volume":"110","author":"Han","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","first-page":"A835","DOI":"10.1210\/jendso\/bvac150.1727","article-title":"PSAT350 autoimmune polyglandular syndrome type II presenting with Hashimoto's thyroiditis, diabetes mellitus type I and Addison's disease: A case report","volume":"6","author":"Barjose","year":"2022","journal-title":"J Endocr Soc"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26020540","article-title":"Non-hypertensive effects of aldosterone","volume":"26","author":"Ekman","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071767","article-title":"Renin-angiotensin-aldosterone system and immunomodulation: A state-of-the-art review","volume":"10","author":"Laghlam","year":"2021","journal-title":"Cells"},{"key":"B23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4049\/jimmunol.0802886","article-title":"Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity","volume":"184","author":"Herrada","year":"2010","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-2032-6","article-title":"Coexistence of primary aldosteronism and Hashimoto's thyroiditis","volume":"32","author":"Krysiak","year":"2012","journal-title":"Rheumatol Int"},{"key":"B25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jash.2014.10.009","article-title":"Prevalence of angiotensin II type 1 receptor (AT1R)-activating autoantibodies in primary aldosteronism","volume":"9","author":"Li","year":"2015","journal-title":"J Am Soc Hypertension JASH"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3282","article-title":"Autoimmune mechanisms activating the angiotensin AT1 receptor in 'primary' aldosteronism","volume":"99","author":"Kem","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13388","article-title":"AT1AA (angiotensin II type-1 receptor autoantibodies): Cause or consequence of human primary aldosteronism","volume":"74","author":"Piazza","year":"2019","journal-title":"Hypertension (Dallas Tex 1979)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa553","article-title":"ICPis-induced autoimmune polyendocrine syndrome type 2: A review of the literature and a protocol for optimal management","volume":"105","author":"Shi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2147\/IMCRJ.S515059","article-title":"Autoimmune polyglandular syndrome type 2 presentation with alopecia universalis, Hashimoto's disease, and Addison's disease","volume":"18","author":"Sales-Morales","year":"2025","journal-title":"Int Med Case Rep J"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/er.23.3.327","article-title":"Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: Autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction","volume":"23","author":"Betterle","year":"2002","journal-title":"Endocr Rev"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1954159\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:43:57Z","timestamp":1790228637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1954159\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":30,"alternative-id":["10.3389\/fimmu.2026.1954159"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1954159","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"article-number":"1954159"}}